A Long-term Safety Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes
Clinical trial NCT06010004 · COMPLETED
Trial details
- NCT number
- NCT06010004
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-28
- Primary completion
- 2025-06-05
- Enrollment
- 401
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.